Prednisone

Prednisone, a widely used corticosteroid medication, has been the subject of numerous clinical trials exploring its effectiveness in treating various conditions. This article examines recent studies investigating prednisone’s use in managing diseases such as asthma, lupus, rheumatoid arthritis, heart failure, and chronic obstructive pulmonary disease (COPD). We’ll look at different formulations, dosages, and potential benefits of prednisone across these diverse medical applications.

Table of Contents

What is Prednisone?

Prednisone is a medication that belongs to a class of drugs called corticosteroids or glucocorticoids. It is a synthetic version of cortisol, a hormone naturally produced by the adrenal glands in your body. Prednisone is widely used for its powerful anti-inflammatory and immunosuppressive properties[1].

This medication is available under various brand names, including Cortancyl and Decortin H. It’s important to note that prednisone is different from prednisolone, which is another corticosteroid medication[2][3].

Conditions Treated with Prednisone

Prednisone is used to treat a wide range of conditions, including:

  • Rheumatoid Arthritis (RA): A chronic inflammatory disorder affecting the joints[1]
  • Systemic Lupus Erythematosus (SLE): An autoimmune disease that can affect various parts of the body[4]
  • Multiple Myeloma: A type of blood cancer that affects plasma cells[5][6]
  • Asthma: A condition that affects the airways and causes breathing difficulties[3]
  • Calcium Pyrophosphate Deposition (CPPD) Arthritis: Also known as pseudogout, a type of arthritis caused by crystal deposits in the joints[2]
  • Achalasia: A rare disorder of the esophagus that makes it difficult to swallow food[7]

How Prednisone Works

Prednisone works by mimicking the effects of cortisol in your body. It reduces inflammation and suppresses the immune system, which can help alleviate symptoms in various conditions[1].

In conditions like rheumatoid arthritis, prednisone helps reduce joint pain, swelling, and stiffness. For asthma patients, it can help reduce airway inflammation and improve breathing[3].

In blood cancers like multiple myeloma, prednisone is often used in combination with other drugs to help kill cancer cells and reduce inflammation[5].

Dosage Forms and Administration

Prednisone is available in several forms:

  • Oral tablets: These come in various strengths, typically ranging from 1 mg to 20 mg[2]
  • Modified-release tablets: These are designed to release the medication at specific times, which can be helpful for conditions with symptoms that worsen at night or early morning[3]

The dosage and duration of treatment can vary greatly depending on the condition being treated and the individual patient’s response. For example:

  • For rheumatoid arthritis, doses may range from 5 mg to 10 mg daily[1]
  • For acute CPPD arthritis, a dose of 20 mg daily might be used[2]
  • In multiple myeloma treatment, prednisone might be given at 60 mg/m² for 4 days as part of a combination therapy[5]

It’s crucial to follow your doctor’s instructions carefully when taking prednisone. Never stop taking the medication abruptly without medical supervision, as this can lead to withdrawal symptoms.

Potential Side Effects

While prednisone can be very effective, it can also cause side effects, especially when used at higher doses or for long periods. Some potential side effects include[2]:

  • Gastrointestinal issues: Nausea, vomiting, abdominal pain
  • Increased blood sugar levels
  • Sleep disturbances
  • Mood changes or irritability
  • Increased blood pressure
  • Changes in kidney function

Long-term use of prednisone may lead to more serious side effects, such as osteoporosis, increased risk of infections, and adrenal suppression. Your doctor will monitor you closely for these potential effects[1].

Ongoing Research and Clinical Trials

Researchers continue to study prednisone to better understand its effects and explore new uses. Some areas of ongoing research include:

  • Comparing prednisone to other treatments for various conditions, such as colchicine for CPPD arthritis[2]
  • Investigating modified-release formulations of prednisone for better management of nocturnal asthma symptoms[3]
  • Studying the effectiveness of prednisone in combination with other drugs for multiple myeloma treatment[8]
  • Exploring the use of prednisone in treating fatigue associated with systemic lupus erythematosus[4]

These ongoing studies aim to improve our understanding of prednisone and optimize its use in various medical conditions.

Condition Prednisone Formulation Key Findings/Objectives
Nocturnal Asthma Modified-release (Lodotra) Evaluated efficacy on nocturnal symptoms compared to immediate-release prednisone
Lupus Delayed-release (RAYOS) Compared effect on fatigue to immediate-release prednisone
Rheumatoid Arthritis Delayed-release (RAYOS) Assessed effectiveness on disease activity and morning stiffness
Heart Failure Standard prednisone Examined efficacy of different doses (15, 30, 60 mg/day) on diuresis
COPD Standard prednisone Studied effect on gene expression in stable COPD patients
Chondrocalcinosis (CPPD) Standard prednisone Compared efficacy and safety to colchicine for acute CPPD arthritis

Ongoing Clinical Trials on Prednisone

  • Study on Optimizing Immunosuppressive Treatment for Living Donor Kidney Transplant Patients Using Prednisone, Basiliximab, and Tacrolimus Monohydrate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study of Brentuximab Vedotin with Drug Combination for Untreated CD30-expressing Peripheral T-cell Lymphoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Czechia
  • Study on Severe Erythema Multiforme: Comparing Methylprednisolone Acetate and Lidocaine Hydrochloride Monohydrate with Placebo for Hospitalized Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Effectiveness of AGTC-501 for Men with X-linked Retinitis Pigmentosa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study Comparing Two Prednisone Treatment Plans for Patients with Giant Cell Arteritis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Study on the Safety of LY3884961 for Patients with Type 1 Gaucher Disease

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Germany Spain
  • Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

    Not yet recruiting

    3 1 1 1
    Denmark Estonia Finland Italy Norway Sweden
  • Study on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria France Germany Italy The Netherlands Portugal +1
  • Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

    Not recruiting

    2 1 1
    Investigated Drugs:
    Czechia France Germany Italy Spain

Glossary

  • Prednisone: A corticosteroid medication used to treat various inflammatory conditions and autoimmune disorders.
  • Modified-release prednisone: A formulation of prednisone designed to release the medication at specific times, such as during the night, to better manage symptoms.
  • RAYOS: A brand name for delayed-release prednisone, used in some clinical trials for conditions like rheumatoid arthritis and lupus.
  • Lodotra: Another brand name for modified-release prednisone, studied for use in conditions like nocturnal asthma.
  • DAS28: Disease Activity Score in 28 Joints, a measure used to assess the activity of rheumatoid arthritis in clinical trials.
  • FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue, a tool used to measure fatigue in patients with chronic illnesses like lupus.
  • Acute exacerbation of COPD (AECOPD): A sudden worsening of COPD symptoms that often requires additional treatment or hospitalization.
  • Chondrocalcinosis: Also known as calcium pyrophosphate deposition (CPPD) disease, a condition where calcium crystals form in joint cartilage, causing arthritis-like symptoms.
  • Diuresis: Increased production of urine, often a goal in treating heart failure to reduce fluid overload.
  • Gene expression: The process by which information from a gene is used to create a functional gene product, often a protein.

References

  1. https://clinicaltrials.gov/study/NCT01393639
  2. https://clinicaltrials.gov/study/NCT03128905
  3. https://clinicaltrials.gov/study/NCT00686335
  4. https://clinicaltrials.gov/study/NCT03098823
  5. https://clinicaltrials.gov/study/NCT01063179
  6. https://clinicaltrials.gov/study/NCT00551928
  7. https://clinicaltrials.gov/study/NCT01903486
  8. https://clinicaltrials.eu/trial/study-comparing-bortezomib-melphalan-prednisone-lenalidomide-and-daratumumab-for-multiple-myeloma-in-patients-ineligible-for-stem-cell-transplant/